Literature DB >> 23355592

Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation.

Nélia Ferraria1, Susana Rocha, Vera Silva Fernandes, Teresa Correia, Elisabete Gonçalves.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple manifestations in several organs and systems. Neuropsychiatric manifestations can occur in 22-95% of paediatric cases, being much less frequent as an initial clinical event. We report a case of SLE, presenting primarily with neuropsychiatric symptoms. An African-descendant 7-year-old girl was admitted with a 4-day history of ataxia, diplopia and morning vomiting, as well as severe headache, psychiatric symptoms and cognitive dysfunction beginning 1 year prior to admission. Brain MRI was suggestive of encephalitis. Investigation excluded infectious aetiology. Immunological markers revealed high titre of antinuclear and anti-double-stranded DNA antibodies. Neuropsychiatric lupus (NPL) was considered, and cyclophosphamide and methylprednisolone pulses were started, with good initial response. Clinical deterioration motivated therapy with azathioprine with subsequent clinical stabilisation and a latent cognitive dysfunction. In unusual encephalitis presentation, a wide range of differential diagnosis has to be considered. Primary NPL presents difficult diagnostic and therapeutic challenges.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23355592      PMCID: PMC3603605          DOI: 10.1136/bcr-2012-008270

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

Review 1.  Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature.

Authors:  Raphael Szalat; Pascale Ghillani-Dalbin; Moez Jallouli; Zahir Amoura; Lucile Musset; Patrice Cacoub; Damien Sène
Journal:  Autoimmun Rev       Date:  2010-05-10       Impact factor: 9.754

Review 2.  Neuropsychiatric lupus.

Authors:  J G Hanly
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

3.  Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage.

Authors:  Hermine I Brunner; Earl D Silverman; Theresa To; Claire Bombardier; Brian M Feldman
Journal:  Arthritis Rheum       Date:  2002-02

4.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Authors:  Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-08

Review 5.  Neurolupus.

Authors:  Fady G Joseph; Neil J Scolding
Journal:  Pract Neurol       Date:  2010-02

6.  Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.

Authors:  Linda T Hiraki; Susanne M Benseler; Pascal N Tyrrell; Diane Hebert; Elizabeth Harvey; Earl D Silverman
Journal:  J Pediatr       Date:  2007-11-05       Impact factor: 4.406

Review 7.  Neurologic manifestations of systemic lupus erythematosus in children and adults.

Authors:  Eyal Muscal; Robin L Brey
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

8.  The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus.

Authors:  Wilmer L Sibbitt; John R Brandt; Courtney R Johnson; Marcos E Maldonado; Samir R Patel; Corey C Ford; Arthur D Bankhurst; William M Brooks
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

9.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

Authors:  L B Tucker; A G Uribe; M Fernández; L M Vilá; G McGwin; M Apte; B J Fessler; H M Bastian; J D Reveille; G S Alarcón
Journal:  Lupus       Date:  2008-04       Impact factor: 2.911

Review 10.  MRI and the brain in systemic lupus erythematosus.

Authors:  J W Graham; W Jan
Journal:  Lupus       Date:  2003       Impact factor: 2.911

View more
  4 in total

1.  Depression as the First Manifestation in a Young Girl With Juvenile Systemic Lupus Erythematosus.

Authors:  Tania Caroline Monteiro DE Castro; Ho Chi Hsien
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

Review 2.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

3.  Course of Neuropsychiatric Symptoms during Flares of Systemic Lupus Erythematosus (SLE).

Authors:  Gareth Garrett; Nicola Ambrose; Zaib Davids; Dorothea Bindman
Journal:  Case Rep Psychiatry       Date:  2017-02-23

4.  Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature.

Authors:  Alexandra Theisen; Paroma Bose; Christina Knight; Melissa Oliver
Journal:  Pediatr Rheumatol Online J       Date:  2020-07-13       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.